FDA approves 1st nonopioid drug to ease withdrawal symptoms
TRENTON, N.J. (AP) — Federal regulators have approved the first nonopioid treatment to ease withdrawal symptoms from quitting addictive opioids.
The U.S. Food and Drug Administration expedited approval of Lucemyra (luc-eh-MEER'-eh) to help combat the U.S. opioid epidemic.
The tablet was approved Wednesday to treat adults for up to two weeks for common withdrawal symptoms like vomiting, diarrhea, muscle pain and agitation. It is not an addiction treatment but can be part of a longer-term plan.
People going through detox are usually given opioid medicine like methadone, which eases the... read more
- 01:02 Congressional leaders get briefings on Russia probe
- 17:04 'It's about time': Trump pardons late boxer Jack Johnson
- 16:13 Ted Cruz says injured Santa Fe students told him 'donât take our...
- 16:01 Democrat gubernatorial candidate Valdez owes $12K in overdue...
- 15:27 Trump awards Medal of Honor to Navy SEAL in Afghan assault
- 14:45 Stormy Daniels' lawyer seeks permission to depose Trump